Trilostane API Manufacturers

Looking for Trilostane API 13647-35-3?

Description:

Here you will find a list of producers, manufacturers and traders of Trilostane. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Trilostane 

Synonyms:

Trilostano , Trilostanum  

Cas Number:

13647-35-3 

DrugBank number:

DB01108 

Unique Ingredient Identifier:

L0FPV48Q5R

Trilostane is a type of Adrenocortical suppressants

Adrenocortical suppressants belong to the subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are specifically designed to target and regulate the functioning of the adrenal cortex. These suppressants act by inhibiting the production or release of hormones, such as glucocorticoids and mineralocorticoids, which are synthesized and secreted by the adrenal glands.

Adrenocortical suppressants play a crucial role in the management of various medical conditions associated with excessive adrenal gland activity, such as Cushing's syndrome, hyperaldosteronism, and certain autoimmune disorders. They are also utilized in organ transplantation to prevent rejection and as adjunctive therapy in the treatment of certain cancers.

Commonly used adrenocortical suppressants include corticosteroids like dexamethasone, prednisone, and hydrocortisone, which exert potent anti-inflammatory and immunosuppressive effects. These medications can be administered orally, topically, or through injection, depending on the specific medical indication.

The effectiveness of adrenocortical suppressants lies in their ability to modulate the body's immune response and reduce inflammation by inhibiting key enzymes and factors involved in the production of adrenal hormones. By dampening the activity of the adrenal cortex, these medications help alleviate symptoms associated with adrenal dysfunction and provide relief to patients.

As with any pharmaceutical API, the use of adrenocortical suppressants requires careful monitoring and supervision by healthcare professionals due to potential side effects and interactions with other medications. Proper dosage adjustment and adherence to treatment guidelines are crucial to ensure optimal therapeutic outcomes and minimize the risk of adverse events.

In conclusion, adrenocortical suppressants are an essential class of pharmaceutical APIs utilized to regulate adrenal gland activity in the treatment of various medical conditions. Their anti-inflammatory and immunosuppressive properties make them valuable therapeutic agents, but their use should always be guided by medical professionals to ensure safe and effective treatment.

Trilostane (Adrenocortical suppressants), classified under Hormonal Agents

Hormonal agents are a prominent category of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These substances play a crucial role in regulating and modulating hormonal functions within the body. Hormonal agents are designed to mimic or manipulate the effects of naturally occurring hormones, allowing healthcare professionals to treat various endocrine disorders and hormonal imbalances.

Hormonal agents are commonly employed in the treatment of conditions such as hypothyroidism, hyperthyroidism, diabetes, and hormonal cancers. These APIs work by interacting with specific hormone receptors, either by stimulating or inhibiting their activity, to restore the balance of hormones in the body. They can be administered orally, intravenously, or through other routes depending on the specific medication and patient needs.

Pharmaceutical companies employ rigorous manufacturing processes and quality control measures to ensure the purity, potency, and safety of hormonal agent APIs. These APIs are synthesized using chemical or biotechnological methods, often starting from natural hormone sources or through recombinant DNA technology. Stringent regulatory guidelines are in place to guarantee the efficacy and safety of hormonal agent APIs, ensuring that patients receive high-quality medications.

As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on enhancing the effectiveness and reducing the side effects of hormonal agent APIs. This includes the exploration of novel delivery systems, advanced formulations, and targeted drug delivery methods. By continuously advancing our understanding and capabilities in hormonal agents, the medical community can improve patient outcomes and quality of life for individuals with hormonal disorders.

• Shandong Octagon Chemicals Limited from China, product country of origin China
• Xi'an ZB Biotech Co., Ltd from China, product country of origin China
• Sinoway industrial Co.,Ltd from China, product country of origin China
• Otto Brandes GmbH from Germany, product country of origin Unknown
• STEROID S. p. A. from Italy, product country of origin Italy

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.